Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Recurrence in Depression With Drugs and CT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Recurrent or chronic major depressive disorder~Exclusion Criteria:~* Current diagnosis of psychotic affective disorder~* History of nonaffective psychotic disorder~* Substance dependence last three months requiring detox~* Schizotypal, antisocial, or borderline personality disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cognitive therapy plus medications (Type: EXPERIMENTAL): Participants will receive antidepressant medication plus cognitive therapy
- Medications alone (Type: EXPERIMENTAL): Participants will receive maintenance of antidepressant medication alone

Based on this trial design, predict the completion outcome and termination type (if applicable).